Extent of Protocol deviation accepted by the Agency [Regulatives / Guidelines]

posted by bharathi – India, 2014-09-16 14:19 (4304 d 06:31 ago) – Posting: # 13519
Views: 5,581

Dear All,

I am performing fasting and fed Bioequivalence studies for an X product. Design of the study is parallel as recommended by the Agency.

Fasting and Fed studies are divided each into 2 groups.

Fed study was completed with 2 groups (Each group with 40 subjects, 20 each of test and reference.

Analysis was done and proved to be bioequivalent.

In fasting study, only group 1 is completed and there's no time for the group 2 to be completed. So can I analyze and if it is bioequivalent, will Agency accepts by proposal (deviation from the protocol that group 2 was not performed?)

Please can you clarify the same

Regards,
Bharathi

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
191 visitors (0 registered, 191 guests [including 21 identified bots]).
Forum time: 20:50 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5